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Understanding the signals that imprint tissue-specific immune cell homing might result in novel approaches to target inflammatory disease. Marelli-Berg and colleagues report that hepatocyte growth factor binding to its receptor c-Met instructs T cell homing to the heart, and pharmacological blockade of c-Met prevents T-cell-mediated inflammation in the heart but not the skin.
INTRODUCTION
The migratory patterns of naive and memory T lymphocytes are well defined and vary depending on their activation, differentiation, and function. Through expression of a unique set of adhesion molecules and chemokine receptors, so-called ''homing'' receptors, distinct memory T cell populations are able to interact with organ-specific endothelial cells (ECs) and are recruited to distinct target tissues. For example, lymphocyte trafficking to the intestinal lamina propria is mediated by the interaction between intestinal mucosal addressin cell adhesion molecule-1 expressed by gut endothelium, and lymphocyte a 4 b 7 integrin. T cell migration to the skin is promoted by cutaneous lymphocyteassociated antigen (CLA) interaction with vascular E-selectin with the involvement of chemokine-receptor pairs CCR4-CCL17, CCR10-CCL27, and CCR8-CCL1 (McCully et al., 2012; Mora and von Andrian, 2006) .
During antigen activation of naive T cells, the microenvironment of the draining lymphoid tissue provides vital cues for the acquisition of peripheral homing preference. For example, dendritic cells (DCs) derived from gut-associated lymphoid tissue (GALT) have been shown to instruct gut tropism, via the production of retinoic acid from vitamin A (Mora and von Andrian, 2006) . Similarly, skin DCs produce the vitamin D3 metabolite 1,25(OH) 2 D 3 , which favors the induction of skin-homing lymphocytes (Mora and von Andrian, 2006) . With the exception of gut and skin, the molecular signature and imprinting mechanisms that define preferential homing to other organs are largely elusive. Most studies have focused on the role of adhesion and chemokine receptors, but the extensive overlap in the expression of these molecules by lymphocytes retrieved from different tissues has prevented the identification of tissue-selective area codes.
It has been recently proposed that soluble factors produced by the tissue itself might contribute to T cell homing imprinting. For example, skin-derived soluble factors have been shown to induce the skin homing receptor CCR8 in T cells (McCully et al., 2012) . It is known that tissue-derived small molecules can be directly delivered to draining lymph nodes by anatomically defined conduits (Gretz et al., 2000) . Some of these molecules are produced in a tissue-specific manner and can therefore define the topographic identity of the tissue where they are generated in the draining lymphoid tissue and possibly contribute to T cell homing imprinting (Campbell et al., 2003) .
HGF is a pleiotropic cytokine that plays important functions in organ development, regeneration, and cancer by activating its tyrosine kinase receptor c-Met (Zhang and Vande Woude, 2003) . A key feature of HGF is its ability to promote cell migration (Zhang and Vande Woude, 2003) . In immune processes, HGF can induce chemotactic responses by liver-derived human T lymphocytes (Adams et al., 1994) and maintains the differentiation of human hepatic sinusoidal endothelial cells, which specialize in lymphocyte recruitment to the liver (Lalor et al., 2006) . The HGF-c-Met axis has also been implicated in the mobilization of cardiac progenitor cells (Leri et al., 2005) . Based on these reports, we have investigated the effects of T cell exposure to HGF during activation on their migration and homing patterns. Our findings reveal that engagement of HGF-c-Met axis during priming induces ''heart-homing'' signature T cells and also indirectly mediates their recirculation in cardiac tissue.
RESULTS

Engagement of the HGF-c-Met Axis during Activation Induces Distinctive Migratory Features in T Cells
To investigate the effects of HGF on T cell migration, we first assessed the expression of the HGF receptor c-Met and the effects of its stimulation on T cell functions. Naive T (Tn) cells were found to express low amounts of c-Met ( Figure 1A ) and displayed modest but reproducible migratory responses to HGF (Figure 1B) , which were prevented by pre-treatment with the c-Met-specific inhibitor PHA-665752 (Rodig and Shapiro, 2010) or by selective inhibition of c-Met in T cells with lentiviral-delivered, specific shRNAs (Figures S1A-S1C), which confirmed the specificity of the c-Met small molecule inhibitor. In contrast, c-Met inhibition did not affect T cell migration induced by the chemokines CCL19 and CCL21 ( Figure 1C ), which stimulate naive T cell migration via CCR7 (Okada et al., 1998) . Naive T cells were subsequently activated for 7 days by plastic-bound anti-CD3 and anti-CD28 antibodies either in the presence (Thgf) or absence (Tnt) of HGF, which was added at a concentration of 15 ng/ml, a dose determined by preliminary experiments of HGF-induced chemokinesis by naive T cells. Exposure to HGF during activation did not affect T cell division or cytokine production (Figures S1F-S1I). In contrast, only Thgf cells upregulated c-Met ( Figures 1D, 1E , and S1J-S1L) and maintained the ability to migrate to this cytokine, which was prevented by the c-Met inhibitor (Figures 1F and 1G) . The inhibitor did not affect either spontaneous migration of Thgf or Tnt cells or migration of Thgf cells in response to the chemokine CCL5 ( Figures 1G-1I ), which induces migration of activated T cells (Okada et al., 1998) . In addition, we observed that the presence of HGF increased adhesion of Thgf cells to VCAM-1 in a flow system ( Figures S1M and S1N ), suggesting that c-Met signaling might enhance integrin-mediated adhesion, as previously reported (Zhang and Vande Woude, 2003) . c-Met-mediated migratory responses to HGF were mediated by an Akt-dependent pathway, which was not activated in c-Met-negative Tnt cells ( Figures S2A-S2F ). In addition, HGF-induced chemokinesis required signal transducer and activator of transcription 3 (STAT3) activity (Figures S2G and S2H) , which has been reported to be dispensable for chemokine receptor signaling (Khabbazi et al., 2013) .
We further investigated the migratory signature induced in T cells by HGF by comparing the phenotype of Thgf and Tnt cells. Expression of a number of surface molecules ( Figure S2I ) and migratory characteristics also revealed that, compared to Tnt cells, Thgf cells expressed higher amounts of the chemokine receptor CXCR3 (Figures 1J and 1K) , which correlated with enhanced chemotactic responses to CXCL10 and increased responsiveness to CCL22, this occurring with various degrees of upregulation of its receptor CCR4 ( Figures 1L-1O) .
Overall, these data indicate that signals induced by the HGF-c-Met axis during T cell activation favor the emergence of a T cell population with distinctive migratory features, including c-Met expression and the ability to migrate in response to HGF via an Akt-and STAT3-dependent pathway.
c-Met Promotes T Cell Migration by Inducing Autocrine Chemokine Release
Although HGF has been defined as a chemoattractant by a number of studies (Zhang and Vande Woude, 2003) , its cognate receptor c-Met does not belong to the G protein-coupled receptor family, the canonical trans-membrane proteins that transduce chemotactic activity. Many of them effect of c-Met signaling, including activation of integrins and intracellular mediators of cytoskeleton rearrangements (Zhang and Vande Woude, 2003) , and our own observations that HGF induces chemokinesis and T cell adhesion (Figures 1, S1M , and S1N) closely resemble those of chemokine receptors. We therefore investigated in more depth the mechanism of HGF-induced chemokinesis. First, the effect of Thgf cell pretreatment with the GPCR-G 1 inhibitor pertussis toxin (PTX) on HGF-induced chemokinesis was investigated in vitro and in vivo. As shown in Figure 2A , PTX treatment abrogated Thgf cell migration elicited by HGF in transwell. In vivo, migration of adoptively transferred (i.v.) Thgf cells to the peritoneal cavity of mice, which received HGF (100 ng/mouse) i.p. 30 min earlier, was inhibited by T cell pretreatment with PTX ( Figures 2B and 2C ). These observations suggest that GPCR-Gai signals are mediating HGF-induced chemokinesis, implying a crosstalk between c-Met and these receptors.
Although c-Met has been described to be physically associated to-and potentiate signaling of-other membrane receptors, including integrins (Trusolino et al., 2001) , the possibility that c-Met might increase GPCR signaling is unlikely based on the observation that Thgf cells do not display enhanced responses to CCL5 (as previously shown in Figure 1I ). In addition, HGF stimulation of a variety of cells has been shown to induce chemokine production and secretion (Kaibori et al., 2006; Matsuda-Hashii et al., 2004; Tu et al., 2009 ). We therefore investigated the alternative possibility that c-Met triggering might indirectly induce chemokinesis by stimulating the release of GPCR ligands by the T cell itself. Migration of Tnt cells-which do not migrate in response to HGF-to supernatants (SNs) from Thgf cells unstimulated or re-exposed to HGF overnight was measured in a transwell assay. As shown in Figure 2D , Tnt cells migrated in response to SNs from Thgf cells stimulated with HGF but not those kept in medium alone. As expected, HGF alone did not induce chemokinesis of Tnt cells, thus ruling out the possibility of chemokinesis induced by HGF contained in the SNs. These data suggest that c-Met might increase chemokinesis of Thgf cells by inducing the release of GPCR ligands.
T lymphocytes have been reported to secrete members of the b-chemokine family, particularly CCL4, which in turn can affect T cells in an autocrine loop (Casazza et al., 2009; Tanaka et al., 1998) . We therefore investigated the production of CCL4 by Thgf cells either stimulated with HGF overnight or unstimulated, and we observed an increase in intracellular CCL4 contained in large vesicles in Thgf cells after stimulation with HGF ( Figures 2E-2G ). Antibody neutralization of CCL4 significantly inhibited migration of Tnt cells in response to SNs obtained from Thgf cells re-stimulated with HGF ( Figure 2H ). Further, CCL4 neutralization inhibited Thgf cell adhesion to VCAM-1 in a flow chamber system ( Figure 2I ), suggesting that c-Met signals not only promote CCL4 production, but also induce its release from the T cell. This, (A-C) Naive T (Tn) cells were isolated from lymph nodes of C57BL/6 mice. In (A), expression of the HGF receptor c-Met is shown. Naive T cell (10 6 cells/well) migration in response to HGF (15 ng/ml) (B) or to CCL19/21 (200 ng/ml) (C) was measured by transwell assay at the indicated time points. In some instances, T cells were treated with the c-Met inhibitor (INH) PHA-665752 (0.3 ng/ml) overnight at 37 C prior to the migration assay.
(D-I) Naive T cells were subsequently activated by plastic-bound anti-CD3 and anti-CD28 antibodies in the presence of HGF (Thgf) or in medium alone (Tnt). c-Met expression by Thgf and Tnt 24 hr after stimulation is shown in (D), and the mean differential MFI (MFI cMet À MFI IsC ) in three experiments of identical design is shown in (E). T cells were harvested after a week of culture and their migratory responses to HGF (F) measured by transwell assays. Some T cells were pretreated with the c-Met inhibitor (INH) PHA-665752 (0.3 ng/ml) overnight at 37 C (G and H). Chemokinesis of Thgf and Tnt cells in response to CCL5 (100 ng/ml) is shown in (I). 
Figure 2. Mechanisms of c-Met-Induced Migration
(A-C) Thgf cell migration in response to HGF (15 ng/ml) (B) or to CXCL10 (200 ng/ml) (C) was measured by transwell assays in vitro (A) and by assessing their migration to i.p.-administered HGF (100 ng/mouse) and CXCL10 (1,200 ng/mouse) upon adoptive transfer into syngeneic recipients in vivo (B and C). In some instances, T cells were treated with the GPCR (G1) inhibitor pertussis toxin (PTX, 0.1 ng/ml) for 1 hr at 37 C prior to use.
(legend continued on next page) in turn, could enhance adhesion and migration via GPCR stimulation.
Similarly, a number of other chemokines that have been implicated in heart transplant rejection (Schnickel et al., 2008; Hü ser et al., 2005) were detected in Thgf cells including other CCR5 ligands (CCL3, CCL5) and the CCR4 ligands CCL22 and CCL17, which are increased by c-Met signals (except CCL17) ( Figure S3 ).
The molecular mechanisms of c-Met-induced CXCR3 and CCR4 expression and responsiveness were further investigated by a series of in vitro experiments, which revealed that STAT-3 activation by c-Met is instrumental for the increased expression and responsiveness of these chemokine receptors by Thgf cells ( Figure S4 ).
HGF Is Produced in the Cardiac Parenchyma and Instructs T Cell Cardiotropism
In addition to its canonical source, the liver, HGF has been previously invoked to be present in heart tissue where it is required for the mobilization of cardiac stem cells (Leri et al., 2005) . In animal models, HGF is transiently produced in the heart upon myocardial ischemic injury (Ono et al., 1997) , which in humans can be followed by autoimmune responses against cardiac tissue.
To identify physiologic sites of T cell priming in the presence of HGF, we analyzed and compared the production of HGF mRNA by a number of murine tissues, including liver and heart, both in steady-state conditions and 24 hr after the injection of 100 mg LPS. As shown in Figures 3A-3C , in addition to the liver, heart parenchyma was found to express HGF mRNA, particularly in inflammatory settings provoked by endotoxin. Immunohistochemical analysis confirmed that this cytokine is constitutively present in low amounts in cardiac tissue, and it is upregulated by inflammatory stimuli induced by LPS ( Figure 3C ). In addition, mRNA transcripts for the chemokine CXCL10, but not CCL4 or CCR4 ligands, were found induced in inflamed cardiac tissue ( Figure 3D ).
Given the ability of HGF to affect the reprogramming of migratory receptors in T cells, we subsequently sought to investigate its distribution within the cardiac parenchyma and heart-draining LNs. Analysis of murine cardiac tissue and draining LNs confirmed the presence of endogenous HGF in both tissues where it co-localized with CD11c + and CD31 + cells (Figures S5A and S5B) , suggesting that locally produced HGF is displayed by DCs and the vasculature-probably via binding to glycosaminoglycans (GAGS), which are used by both cell types to immobilize chemokines and growth factors (Bao et al., 2010; Hartmann et al., 1998; Santiago et al., 2012) . Thus, it is likely that HGF produced in the heart parenchyma reaches the draining LNs both by direct transfer (to HEV, possibly via conduits) and bound to migrating DCs. Based on the observations above and the finding that HGF imprints a unique migratory phenotype in T cells, we next sought to establish whether this phenotype correlates with a specific trafficking pattern of T cells activated in the presence of HGF. First, in vitro activated Thgf or Tnt cells were labeled and injected intravenously into syngeneic recipients and their localization to a variety of tissues was assessed by wide-field fluorescence microscopy. As shown in Figure 3E , unlike control Tnt cells, Thgf cells preferentially localized to the heart and the liver compared to other organs, suggesting that HGF contributes to imprinting these homing patterns in T cells. In addition, pre-treatment of Thgf cells with the c-Met inhibitor prevented their localization to the heart, indicating that HGF not only instructs, but also mediates, T cell cardiotropism. In contrast, c-Met inhibition did not affect Thgf cell localization to the liver, suggesting that additional molecular interactions support T cell migration to this organ (Lalor et al., 2002; Shetty et al., 2011) . Similar results were obtained upon selective inhibition of c-Met in T cells with lentiviral-delivered, specific shRNAs ( Figures S1D and S1E) .
Further experiments confirmed that in vivo priming of T cells in the presence of HGF, although not affecting their proliferation and cytokine production ( Figures S5C-S5H ), induced upregulation of c-Met, CCR4, and CXCR3 expression and function ( Figures S5I-S5O ), leading to the acquisition of cardiotropism ( Figures S6A and S6B ).
c-Met, CXCR3, and CCR4 Differentially Contribute to T Cell Migration to the Heart Both CXCR3 and CCR4 have been shown to promote the development of T cell infiltration of cardiac tissue in heart allograft rejection (Hancock et al., 2001; Hü ser et al., 2005) . To establish the relative role of c-Met, CXCR3, and CCR4 in mediating T cell homing to the heart, we performed a series of experiment in which WT Thgf cells were co-injected with differentially labeled Thgf cells generated from CCR4-or CXCR3-deficient mice in saline-or LPS-treated mice. Some CCR4KO or CXCR3KO T cells were also treated with a blocking anti-CXCR3 antibody or CCR4 inhibitor, respectively, prior to adoptive transfer. As shown in Figures 4A and 4C , Thgf cell migration to the heart of saline-treated mice was not affected by lack of either CCR4 or CXCR3. In contrast, migration of CCR4-or CXCR3-deficient Thgf cell to the heart of LPS-treated mice was similarly impaired compared to that of WT Thgf cells ( Figures 4B and 4D ). Additional blockade of either receptor did not further inhibit T cell localization. Co-injected T cells were retrieved in similar numbers in the spleen of recipients, independently of the experimental conditions. These data indicate that both CXCR3-and CCR4-mediated signals are required for T cell infiltration of the heart in inflammatory but not steady-state conditions. Experiments conducted with WT Thgf cells treated with either the CCR4 inhibitor or the CXCR3 blocking antibody prior to adoptive transfer confirmed that both receptors are required for entry of the T cells in the heart of LPS-treated animals ( Figures S6C-S6F ). In vitro, inhibition of either or both CXCR3 and CCR4 elicited a similar reduction in Thgf cell migration to a combination of CXCL10 and CCL22, further suggesting a crosstalk between the two receptors ( Figure S6G ). As expected, PTX pre-treatment inhibited Thgf cell migration to the heart of non-inflamed mice ( Figure 4E ) consistent with our observation that c-Met signals support their recirculation to cardiac tissue via its effects on GPCRs. Untreated recipients were used in these experiments to minimize Thgf cell recruitment via CCL22 and CXCL10 as observed in LPS-treated recipient mice.
Given our previous observation that Thgf cells produce a number of CCR5 ligands, we sought to confirm the role of these chemokines in mediating T cell cardiotropism by generating CCR5-deficient Thgf cells and monitoring their recruitment to the heart both in non-inflamed and LPS-treated mice. As shown in Figures 4F and 4G , lack of CCR5 expression inhibited Thgf cell migration to the heart both in steady-state and inflammatory conditions. However, CCR5-deficient Thgf cells access to heart tissue of LPS-treated mice was further inhibited by CCR4 or CXCR3 blockade, suggesting that c-Met-mediated production and release of CCR5 ligands provide additional stimuli for the recruitment of cardiotropic T cells during inflammation.
c-Met + CCR4 + Memory T Cells Preferentially Recirculate to the Heart Having established that HGF-induced cardiotropism is associated with the expression of c-Met and CCR4 by memory T cells, we sought to investigate the physiological relevance of this molecular area code by assessing the phenotype of T cells retrieved from cardiac tissue in steady-state conditions and during heart-specific immune responses. To this aim, T cells were retrieved from B6Kd-derived heart allograft and the native heart of C57BL/6 recipients and analyzed for the expression of c-Met and CCR4. This strain combination gives rise to CD8 + T cellmediated direct alloresponses against intact K d molecules and . As a control, CD44 hi T cells retrieved from the spleen were also examined. As shown in Figure 5 , T cells from native and transplanted heart expressed high amounts of c-Met (Figures 5A and 5B) and CCR4 ( Figures 5C and 5D ) compared to memory T cells in the spleen. In addition, a high proportion of heart-resident T cells co-expressed both receptors, including in the lymph nodes draining native hearts ( Figures 5E and 5F ). Localization of labeled T cells in the heart was analyzed 24 hr later by wide-field fluorescence microscopy. T cell localization in the spleen was also assessed to ensure that similar cell numbers had been injected. Representative images are shown in the right side of each panel, with label coding indicated on top. The mean number of cells detected in ten randomly selected fields (103-magnified) from at least three sections of tissue samples from each recipient (±SD) is shown in the left side of each panel. n = 3, N = 2. Scale bars represent 100 mm. **p < 0.01, ***p < 0.005, ****p < 0.001.
CXCR3 expression was similar in all the T cell populations analyzed (not shown), possibly due to the relatively late time point of T cell harvesting.
These observations indicate that c-Met-and CCR4-expressing T cells are enriched in heart tissue both in steady-state and inflammatory conditions, suggesting that expression of these (A-D) T cells were obtained by enzymatic digestion of B6Kd heart allograft 2 weeks after transplantation into C57BL/6 mice (Heart TX ), and from C57BL/6 native hearts (Heart N ). As a control, splenic T cells from naive C57BL/6 mice were used. Memory T cells were identified by gating on the CD44
hi T lymphocyte population.
Expression of the HGF receptor c-Met by CD44 hi CD4 + and CD8 + T lymphocytes from all populations is shown in (A) (representative histograms). Expression of CCR4 by the same T cell populations is shown in (C). The mean MFI of c-Met and CCR4 from three samples are shown in (B) and (D), respectively. (E) Dot plots depict co-expression of c-Met and CCR4 by T cells populations isolated from B6Kd heart allograft 2 weeks after transplantation into C57BL/6 mice (Heart TX ) and from native recipients' hearts (Heart N ) and their draining lymph nodes (dLN Heart N ), and from control spleens. receptors is instrumental for physiological T cell recirculation to the heart and associated lymphoid tissue.
c-Met Blockade Prevents Rejection of Heart Allografts by Promoting Selective Topographic Ignorance
To establish the selectivity of T cell homing imprinting by HGF, we then compared the effect of pharmacological blockade of c-Met on the survival of B6Kd-derived heart or skin grafts transplanted in C57BL/6 recipients. All recipients received a depleting anti-CD8 antibody prior to transplantation (125 mg/mouse i.p. on day -1) (Tsang et al., 2008) to remove potential pre-existing cross-reactive memory alloresponses and ensure that the ensuing response against K d alloantigens is derived from naive T cells (i.e., still susceptible to HGF effects). CD8 + T cell numbers recovered by 72 hr after depletion, as previously described (Tsang et al., 2008) . Some recipients were treated daily with the c-Met inhibitor PHA-665752 i.p. (500 mg/mouse) for 2 weeks after transplantation. This schedule was designed in order to target the priming phase of immunity, when the acquisition of homing properties is known to occur, and to avoid affecting the beneficial effects of HGF on heart tissue, including tissue repair and vascularization (Madonna et al., 2012) . Control groups received saline solution with vehicle alone. As shown in Figures 6A and 6B , pharmacological c-Met blockade led to long-term heart allograft survival in 75% of the recipients compared to controls. In contrast, skin allograft survival was not affected, indicating that c-Met inhibition selectively targets T cell responses against heart tissue irrespective of antigen specificity.
Histological analysis of HE-stained grafts and native heart revealed severe inflammatory lesions in the grafts of recipients treated with vehicle alone, which were attenuated in PHA-665752-treated recipients ( Figures 6C and 6D ).
Co-staining of elastine and smooth muscle cells (SMCs) alpha actin revealed signs of vasculopathy (narrowing of the lumen and perivascular proliferation of SMCs) in vehicle-treated recipients, which were abrogated by the administration of the c-Met inhibitor ( Figures 6C and 6E ). Syngeneic graft and native hearts were free of disease.
Graft infiltration by CD4 + and CD8 + T cells was assessed by immunostaining with anti-CD4 or anti-CD8 primary antibodies followed by AlexaFluor488-conjugated secondary antibody. As shown in Figures 6F and 6G , T cell infiltration of the hearts of PHA-665752-treated mice was reduced compared with that observed in vehicle-treated recipients, particularly in the CD8 + T cell subset, which is in fact responsible for direct allorecognition of K d MHC class I molecules in this combination . T cells separately isolated from heart graft draining or nondraining lymph nodes and the spleen of heart allograft recipients at the time of rejection or 100 days after transplantation displayed strong proliferative responses to B6Kd splenocytes (direct alloresponses; Figure 6H ) and to the K d peptide presented by syngeneic splenocytes ex vivo (indirect alloresponses; Figure 6I) irrespective of the treatment with the c-Met inhibitor and the occurrence of rejection, suggesting that c-Met blockade does not affect T cell priming nor leads to the induction of tolerance. Rather, as confirmed by substantial inhibition of T cell infiltration of heart grafts from inhibitor-treated recipients, c-Met blockade impaired the ability of primed T cells to localize to the heart. Liver-derived human T cells have been shown to migrate in response to HGF in vitro (Adams et al., 1994) . We therefore sought to investigate whether the HGF-mediated induction of cardiotropism in T cells is operational in humans. To this aim, we developed a model of human heart xenograft transplanted subcutaneously in SCID/Beige mice. This model has been previously used to identify molecular patterns of migration to human synovial tissue, lymph nodes, and skin (Garrood et al., 2009 ). Within 2-3 weeks, human heart xenografts become vascularized by mouse vessels, which formed direct anastomosis with the intact human vasculature (Figures S7A-S7C ). Human naive T cells (CD45RO À ), isolated by immunomagnetic negative selection, were activated with plastic-bound anti-CD3 and anti-CD28 antibodies in the presence or absence of HGF. Because commercially available anti-human c-Met antibodies are not suitable for flow cytometric analysis (Adams et al., 1994) , binding of HGF to human naive, Thgf, and Tnt cells was assessed by incubation with DyLight-488-labeled HGF, which revealed low binding of HGF on naive T cells, which selectively increased in Thgf cells, where it appeared to co-localize on the cell surface with the integrin LFA-1 (Figures S7D-S7F ). Thgf and Tnt cells were then labeled with distinct fluorochromes and injected i.v. into SCID/Beige recipients of a double xenograft of human heart and skin tissue transplanted 4 weeks earlier. Grafts and spleen were retrieved 48 hr later and cell localization analyzed by wide-field fluorescence microscopy. As shown in Figures 7A-7F, Thgf but not Tnt cells were enriched in heart but not skin xenografts. Thgf cell migration to heart tissue was inhibited by pretreatment with the c-Met inhibitor. Although not significant, increased numbers of Thgf cells were retrieved in the recipients' spleen, but the c-Met inhibitor did not alter this effect ( Figures  7G-7I ). Overall, these findings suggest that the induction of T cell cardiotropism via the HGF-c-Met axis is also operational in the human system.
DISCUSSION
The present study describes a novel molecular signature of T cell cardiotropism, which is imprinted in T cells primed in the presence of the cytokine HGF and is characterized by c-Met expression and enhanced CCL22-and CXCL10-induced chemokinesis. In addition to imprinting T cells with cardiotropism, HGF also indirectly promotes migration of T cells to the heart. Based on our observations, HGF produced by the myocardium is transported to the heart-draining LN either passively or bound to DCs. HGF has high affinity for heparan sulfate proteoglycans that sequester the ligand and probably localize the action of HGF-SF only to the surrounding c-Met-expressing cells. We noticed that ectopically administered HGF localizes only on CD11c-expressing cells in skin-draining LNs, suggesting a specialization of HEV in heart-associated lymphoid tissue. Thus, DC-bound HGF is probably responsible for the imprinting of cardiotropism during T cell priming, whereas HGF associated to the vasculature probably contributes to cardiotropic memory T cell recruitment during inflammation.
T cell recruitment to the heart by locally produced HGF appears to be a dominant mechanism during constitutive T cell recirculation and immunosurveillance, as suggested by the observation that c-Met inhibition abrogated T cell localization to cardiac tissue in steady-state conditions. HGF-mediated recruitment occurred indirectly via the induction of chemokine secretion by c-Met-expressing T cells. A similar mechanism has been described in T cell migration induced by IL-6 (McLoughlin et al., 2005) . It is possible that this mechanism also applies to a number of cytokines and growth factors, which have been reported to elicit chemotactic responses by T cells.
During inflammation, the chemokine receptors CCR4 and CXCR3 enhanced T cell recruitment to the heart, as has been previously shown in heart transplantation settings (Hancock et al., 2001; Hü ser et al., 2005) .
Co-expression of the CCR4 and CXCR3 chemokine receptors and high responsiveness to their cognate ligands, which are generally thought to be largely restricted to the T helper type 1 and 2 cell subsets, respectively, in humans (Kitamura et al., 1998) , is a key feature of cardiotropic T cells. Engagement of both receptors was required for T cell access to the heart in inflammatory conditions, in line with previous reports. The contribution of CCR4 and CXCR3 to cardiotropic T cell recruitment appeared to be cooperative rather than additive: lack or inhibition of each or both receptors similarly reduced T cell access to the heart parenchyma. It is possible that these two receptors cross-regulate each other, as has been described in many
GPCRs (Vischer et al., 2011) , including the CXCR3-CCR4 pair in which CXCR3 has been shown to enhance CCR4 responsiveness (Sebastiani et al., 2005) . In contrast, CCR5 signals only partially inhibited T cell localization to the heart during inflammation, which is further reduced by inhibition of CCR4 or CXCR3 in an additive manner. In line with this observation, CCR4 signaling is enhanced by the CXCR3 but not by the CCR5 ligands CCL3 and CCL4 (Sebastiani et al., 2005) . It is interesting to note that in our model, CCR4 and CXCR3 ligands were produced either by the heart (CXCL10) or by Thgf cells (CCL22/CCL17), and that CCL22 was released by T cells after c-Met triggering. These observations raise the alternative or additional possibility that CCR4 might be crucial for T cell recruitment by contributing to HGF ''presentation'' and c-Met triggering by the heart endothelium, while CXCR3 might be important for the retention of recruited T cells in the cardiac parenchyma.
Exposure to HGF during priming also promoted the imprinting of T cell hepatotropism. However, differently from what we observed for cardiotropic T cells, HGF-mediated hepatotropic T cell migration to the liver was only partly reduced by c-Met inhibition. These observations indicate that, although HGF is sufficient for the induction of hepatotropism, molecular interactions other than those mediated by c-Met can mediate T cell recirculation in the liver (Lalor et al., 2002; Shetty et al., 2011) .
Our findings are in line with the recent observation that soluble factors produced in selected tissues and drained in the local lymphatic stations contribute to the topographic imprinting of T cells during activation (McCully et al., 2012) . These observations suggest that specialized, tissue-derived DCs are dispensable in some mechanisms of homing imprinting. Further, the effectiveness of c-Met inhibition in preventing the induction of T cell cardiotropism in a heterotopic heart allograft suggest that the tissue itself dictates the environmental cues that affect T cell differentiation in draining lymph nodes.
The possibility that tissue-specific soluble factors can induce a defined and unique topographic molecular signature paves the way for new investigations aimed to a more comprehensive mapping of organ-selective T cell immunity with a substantial clinical impact. In our study, transient inhibition of HGF-c-Met axis during T cell priming selectively disrupts T cell homing and immune inflammation in the heart without affecting T cell responses in the skin. These findings have immediate implications for the development of novel therapies aimed at selectively targeting heart immunity while preserving immune protection in other sites (organ-selective immunosuppression).
The temporary blockade of c-Met required to achieve this effect should not impact on the well-established long-term beneficial effects of HGF on heart tissue (Hü ser et al., 2005) , as it is also indicated by the minimal pathological signs in the grafts from treated animals.
Notably, disruption of the HGF-c-Met axis did not induce T cell tolerance, as indicated by the presence of primed alloresponses in non-rejectors. Rather, we argue that temporary c-Met inhibition prevented the development of topographic memory of the heart by T cells resulting in their failure to access the heart allograft. Further studies will be required to fully develop the clinical potential of this strategy, including determining the duration and plasticity of HGF-induced cardiotropism in primed T cells. Human heart and skin tissue (xenografts, XG) were transplanted into Beige SCID C.B-17 mice. Purified human naive T cells previously activated by plastic-bound anti-CD3 and anti-CD28 antibodies in the presence of HGF (Thgf) or in medium alone (Tnt) for 7 days were injected i.v. on day 28 after grafting. Grafts were removed 48 hr later, embedded in OCT, and snap frozen. The presence of Thgf cells labeled with PKH-26 (red) or Tnt labeled with CFSE (green) in the heart (A) and skin (D) grafts and the recipient's spleen (G) was assessed by wide-field fluorescence microscopy. In parallel experiments, Thgf and Tnt cells were treated with the c-Met inhibitor (INH) and differentially labeled prior to co-injections in xenograft recipients (combinations: Thgf plus Thgf [INH] and Tnt plus Tnt [INH] ). Representative tissue images of heart (B) and skin (E) xenografts and the recipient's spleen (H) are shown. The mean (±SD) number of labeled T cells counted in at least three 103 fields from sections isolated from eight grafts and the recipient's spleens are shown in (C), (F), and (I) (N = 2, n = 4). ***p < 0.0005, scale bars represent 100 mm.
EXPERIMENTAL PROCEDURES
Heart Transplantation Heterotopic heart transplantation was performed by placing the donor heart into the recipient's (WT and B6Kd) sternomastoid cavity, connecting the aortal branch to the carotid artery and the pulmonary vein to the jugular vein. All grafts and native hearts were evaluated by histopathologic criteria in a single-blinded manner and scored to grade the degree of inflammation from 0 to 4 (0, no inflammation; 1, light focal lymphohistocytic infiltrate; 2, moderate focal lymphohistocytic infiltrate with myocardial involvement; 3, moderate to severe inflammation with focal vasculopathy and myocyte degeneration; 4, severe inflammation, vasculopathy, and myocardial fiber loss). Slides were scanned with an Olympus VS-120 using brightfield mode. Images were analyzed with VS-ASW software.
Luminal occlusion was evaluated by tracing the cross-section of each vessel's internal elastic lamina and lumen using Lucia NIS elements software (Nikon UK) in three transverse sections per graft. All vessels in each section, which demonstrated clear staining of elastin laminar and presence of smooth muscle cell (SMC) alpha-actin, were measured in three sections of each heart.
Isolation of T Cells from Heart Tissue
To isolate T cells from heart tissue, native or transplanted murine hearts were harvested and cut into small pieces. The tissue fragments were digested in 1 ml Hanks medium, containing 608 U/ml Collagenase I (Sigma), 187.5 U/ml Collagenase XI (Sigma), 90 U/ml Hyaluronidase (Sigma), and 90 U/ml DNase (Sigma), for 1 hr at 37 C with agitation. Digested samples were passed through a 70 mm cell strainer to obtain a single-cell suspension and were then washed in FACS buffer before cell surface staining with a 1:200 dilution of conjugated antibodies against CCR4-PE (Biolegend), CXCR3-PerCP (Biolegend), CD4-PECy7 (Biolegend), CD8-APC (Biolegend), and CD44-af450 (eBioscience). Cells were incubated for 1 hr at 4 C before being washed twice in FACS buffer and then fixed with 200 ml Fixation Buffer (eBioscience) for 1 hr at 4 C. Cells were washed twice with Fixation/Permeabilisation buffer before intracellular staining with a 1:200 dilution of FITC-conjugated antibody against c-Met (eBioscience). Cells were incubated for 1 hr at 4 C before being washed twice in Fixation/Permeabilisation buffer and being analyzed on a FACS Fortessa (BD).
HGF Binding to Human T Cells
Permeabilized (cell permeabilization kit, eBioscience) T cells were incubated with Dylight 488-labeled (500 ng/ml, ThermoScientific) human recombinant HGF (Peprotech) and rat-anti mouse CD4 and LFA-1 antibodies for 40 min, followed by washing in PBS. Cells were resuspended in fix buffer and analyzed using ImageStream technology (MK II, Amnis). Data were analyzed with IDEAS 6.0 software (Amnis). For analyses, total cells were gated on in focus and single cells. Single cells were then analyzed for HGF intensity within the total CD4 + LFA-1 + population (mean intensity values shown).
Human Tissue Transplantation into SCID Mice
Small human heart tissue samples were collected from the right atrium and non-ischemic part of the left ventricle in patients undergoing routine coronary bypass surgery and skin tissue was obtained from patients undergoing cosmetic surgery, according to a protocol approved by the local ethical committee and after written informed consent by the patient. Human heart and skin tissue samples (4 3 4 mm) were transplanted into Beige SCID C.B-17 mice. Two small incisions were made in the skin behind each ear of one mouse and the heart biopsies were carefully inserted subcutaneously in a dorsal position distal to the shoulder joints (two transplants per animal). The incisions were closed with a soluble suture. Mice were monitored for 4 weeks before grafts were exteriorized and removed for analysis. Okada, Y., Morimoto, I., Ura, K., Nakano, Y., Tanaka, Y., Nishida, S., Nakamura, T., and Eto, S. (1998). Short-term treatment of recombinant murine interleukin-4 rapidly inhibits bone formation in normal and ovariectomized mice. Bone 22, 361-365. Ono, K., Matsumori, A., Shioi, T., Furukawa, Y., and Sasayama, S. (1997) . STAT3 is a major intracellular mediator of cMet signaling, which, albeit not required for chemokine-induced migration (Khabbazi et al., 2013) , has been previously associated with increased chemokine receptor expression by T cells (McLoughlin et al., 2005) .
Further, responsiveness to the CCR4 ligand CCL22 has been shown to require not only the expression of this receptor, but also its functionality, which is acquired upon IL-4 signaling (Morimoto et al., 2005) . The convergence and reciprocal enhancement of IL-4 receptor and c-Met signaling pathways has been previously documented in myeloid (Day et al., 2002) and lymphoid cells (Avery et al., 2008; Rolling et al., 1996) with STAT3 activation shared by both pathways (Cooney et al., 2011) 
Supplemental Experimental Procedures
Mice
All mice used in this study were between the ages of 4-11 weeks. Male and female C57BL/6 and Beige SCID C.B-17 mice were purchased from Charles River (UK). B6Kd mice which express H-2K d molecules as a transgene on the C57BL/6 background (Honjo et al., 2000) were bred in house. CCR4KO mice have been previously described (Chvatchko et al., 2000) . CCR5 and CXCR3 KO mice were purchased from Jackson Laboratories (US). All the in vivo experiments were conducted under the Home Office regulation following approval by Queen Mary University of London Ethics Committee.
Reagents
The selective Akt inhibitor AZD5363 was purchased from SelleckChem.
Fluorescent dyes PKH26 and CFSE were purchased from Invitrogen and used at a concentration of 5µM and 4µM, respectively. In proliferation assays, cells were labelled with 2µM CFSE. HGF was labelled with Dylight 488 (500ng/ml, Thermo Scientific, UK)
according to manufacturer's instructions.
In activation assays, anti-CD3 and anti-CD28 antibodies from eBioscience/BioLegend were used at 1ug/ml and 5ug/ml, respectively.
Recombinant mouse and human HGF, and the chemokines CXCL10, CCL5, CCL22 and CCL19/21 were purchased from Peprotech (London, UK).
Pertussis toxin (PTX, Sigma) was used at a concentration of 0.1ng/ml.
The rat anti-mouse CD8α depletion antibody, clone 53-6.7, was purchased from eBioscience, and used at a dose of 125µg/mouse.
A hamster anti-mouse CXCR3 blocking antibody and Hamster IgG Control were purchased from Biolegend and used at 200ng/10 6 cells (Uppaluri et al., 2008) .
Neutralizing polyclonal goat anti-mouse CCL4 (R&D Systems) was used at 0.5µg/ml.
The CCR4 antagonist C-021 dihydrochloride was purchased from EMD Millipore and used at 73 nM, as previously described (Ravishankar et al., 2014) .
Antibodies and Flow cytometry
For immunohistochemistry, the following antibodies were used: Armenian hamster anti- Technologies.
All flow cytometry antibodies were used at 1:100 dilutions unless otherwise specified.
The following antibodies were used in this study: PE-conjugated anti-mouse c-Met 
Quantitative real-time polymerase-chain reaction (qRT-PCR)
Tissues were harvested and stored in RNA-later (Qiagen, Crawley, UK) at -80°C until processing. RNA was purified using Trizol reagent according to the manufacturer's instructions (Life Technologies) and assessed for quality and quantity using absorption measurements. Reverse transcription was performed according to the manufacturer's instruction (Applied Biosystems).
Gene expression analysis was done using SYBR Green Supermix (Biorad) in CFX connect light cycler (Biorad), according to the manufacturer's instructions. Expression was calculated using the ΔΔct method (Livak and Schmittgen, 2001 ) and normalized to a housekeeper gene (Gapdh).
Primers for qPCR were designed with the help of online tools (Primer 3Plus) using at with hematoxylin, mounted using xylene-based mounting medium (Permount) and visualized using Zeiss Axiophot microscope.
Cell Culture
Naïve cells isolated from lymph nodes and spleen were activated with plate-bound rat anti-mouse anti-CD3 (1µg/ml, eBioscience, Hatfield, UK) and anti-CD28 (5µg/ml, eBioscience, Hatfield, UK) antibodies. Culture medium consisted of RPMI 1640 supplemented with 10%FCS, 2 mM glutamine, 50 IU/ml penicillin, 50 µg/ml streptomycin, 50 µM 2-mercaptoethanol, 20 mM HEPES, 1 mM sodium pyruvate (Life 
In vitro flow chamber assays
Flow chambers (Ibidi) were coated with recombinant VCAM-1/Fc Chimera (2µg/ml, R&D Sistems) in PBS 2 hours at 37 o C. T cells were counted and resuspended to 1x10 7 cells/ml in Dulbecco phosphate buffered saline (DPBS) containing 0.1% bovine serum albumin (BSA) and kept on ice before use. Immediately prior to flow, 5x10 6 (0.5ml) T cells were diluted to 5ml (1x10 6 cells/ml) in DPBS supplemented with Ca 2+ and Mg
2+
and flowed for 8 min prior to recording. A shear stress of 1 dyne/cm 2 was generated using an automated syringe pump (Harvard Apparatus, South Natick, MA). T cells were perfused for a period of 8min, and six, 10s frames were chosen from random fields of view using a Q-imaging Retiga EXi digital video camera (Q-imaging) and recorded in the total number of interacting cells were quantified as number of cells initially captured during the 10 s frame, which were further classified as either rolling or firmly adherent (those which remain stationary for the 10 s observation period). The total number of interacting cells for each category (rolling and adhesion) was expressed as cells per field, counting six fields per treatment.
Lentivirus preparation
Bacterial glycerol stocks containing sh-RNA plasmid clones targeting c-Met (Mission sh-RNA TRCN0000226122, construct 1, and TRCN0000226124, construct 2), as well as the control sequence, shc003v, in the pLKO.1 lentiviral vector were purchased from Sigma and grown in Luria Bertani broth. Plasmids were isolated using Plasmid Maxi kit (Qiagen). HEK293T cells were grown in 10 x 10cm cell culture dishes to 70% confluence and transfected with plasmids using the calcium phosphate method. The supernatant was harvested 48 and 72 hours after transfection and hundred-fold concentrated in an ultracentrifuge. Aliquots were stored at -80°C.
Lentiviral Transduction and sh-RNA-mediated gene silencing
Primary CD4 + T cells were isolated from C57BL/6 murine lymph nodes and activated with plate bound anti-CD3 and anti-CD28, IL2 and HGF for 3 days. On day 3, medium was changed and cells were incubated with 25µl virus / 10 6 cells in the presence of polybrene (5µg/ml). Virus was removed 24h later; T cells were washed twice with PBS and incubated for 24h in complete RPMI culture media.
Intracellular chemokine staining.
T cells were stimulated with HGF or phorbol-12-myristate-13-acetate (PMA; 10 ng/ml; Sigma-Aldrich) and ionomycin (2µM; Sigma-Aldrich) for 6 hours in the presence of Histochemistry 5um-thick, paraffin-embedded sections were deparaffinised and rehydrated in graded ethanol. Immunoperoxidase staining for SMC using rabbit monoclonal antibody against mouse alpha-actin (1/500 dilution) (#11-84-1, Epitomics, USA) was performed, and DAB used for colour development. After counterstaining with haematoxylin, sections were stained for elastin using standard Miller's Stain protocol. For the purpose of comparison, tissue sections were taken in corresponding regions of the heart (proximal ventricular area).
For immunohistochemistry, tissue sections were incubated with either rat anti-mouse CD4 or CD8 purified antibody, followed by incubation with Alexa488-conjugated anti-rat secondary antibody. Nuclei were counterstained with DAPI and mounted with Vectashield mounting medium (Vector Laboratories). Cell infiltration was evaluated by wide field microscopy and automated cell counting.
Skin grafting
Skin grafting was conducted using a method previously described by Billingham and Medawar (Billingham and Medawar, 1951) using tail skin grafted onto the lateral thorax.
Briefly, donor tail skin was removed and cut into 1cm 2 sections. Recipient mice were anaesthetised using Isoflurane (Halocarbon Products Corp.). A piece of skin was removed from the right flank to create a graft bed and a 1 cm 2 piece of tail skin was placed in the graft bed. The graft was covered with muslin and a plaster cast was then wrapped around the midriff and graft. Plasters were removed 7-10 days after grafting and grafts were inspected every other day. Skin graft rejection was assessed as previously described (Schwoebel et al., 2005) .
Mixed Lymphocyte Reaction
T cells isolated from draining, non-draining lymph nodes and spleens collected from animals at the day of transplant rejection were incubated with either mitomycin Ctreated B6Kd splenocytes or different concentrations of K d peptide (Cambridge Peptides) for 48 hours. The cultures were then pulsed with 1µCi/well 3 Hthymidine overnight, harvested using the Tomtec harvester 96 and filter, and counted using the Wallac Trilux 1450 Microbeta counter for Windows (all from Wallac/Perkin Elmer).
Widefield fluorescence microscopy
Tissues were sampled and embedded in Optimal Cutting Temperature compound (OCT) Three tissue sections were obtained from the top, bottom and middle section of each tissue samples. To minimize effect of arbitrary choice of field, tissue infiltration was quantified by randomly selecting ten 10x-magnified fields and assessing the number of fluorescent cells in each field, as previously described (Mirenda et al., 2007) .
Quantification of T cell infiltrates observed by wide field fluorescence microscopy was performed using a specifically-designed software to run in the LabView (V7.1, National Instruments) environment (Mirenda et al., 2007) , which allows to identify single fluorescent cells within the tissue.
The number of infiltrating cells obtained from each tissue section analyzed was then averaged and assessed statistically. Infiltration is expressed as the mean of fluorescent cells per 10x field in a given experimental condition ± Standard Deviation (SD).
Statistical analysis
